The Market Reports

Index

1 Acute Migraine Medications Market Overview
1.1 Product Overview and Scope of Acute Migraine Medications
1.2 Acute Migraine Medications Segment by Type
1.2.1 Global Acute Migraine Medications Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Medications Segment by Application
1.3.1 Acute Migraine Medications Sales Comparison by Application: (2021-2027)
1.3.2 Drug Stores
1.3.3 Hospital Pharmacies
1.4 Global Acute Migraine Medications Market Size Estimates and Forecasts
1.4.1 Global Acute Migraine Medications Revenue 2016-2027
1.4.2 Global Acute Migraine Medications Sales 2016-2027
1.4.3 Acute Migraine Medications Market Size by Region: 2016 Versus 2021 Versus 2027

2 Acute Migraine Medications Market Competition by Manufacturers
2.1 Global Acute Migraine Medications Sales Market Share by Manufacturers (2016-2021)
2.2 Global Acute Migraine Medications Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Acute Migraine Medications Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Acute Migraine Medications Manufacturing Sites, Area Served, Product Type
2.5 Acute Migraine Medications Market Competitive Situation and Trends
2.5.1 Acute Migraine Medications Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Acute Migraine Medications Players Market Share by Revenue
2.5.3 Global Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Acute Migraine Medications Retrospective Market Scenario by Region
3.1 Global Acute Migraine Medications Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Acute Migraine Medications Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Acute Migraine Medications Market Facts & Figures by Country
3.3.1 North America Acute Migraine Medications Sales by Country
3.3.2 North America Acute Migraine Medications Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Acute Migraine Medications Market Facts & Figures by Country
3.4.1 Europe Acute Migraine Medications Sales by Country
3.4.2 Europe Acute Migraine Medications Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Acute Migraine Medications Market Facts & Figures by Region
3.5.1 Asia Pacific Acute Migraine Medications Sales by Region
3.5.2 Asia Pacific Acute Migraine Medications Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Acute Migraine Medications Market Facts & Figures by Country
3.6.1 Latin America Acute Migraine Medications Sales by Country
3.6.2 Latin America Acute Migraine Medications Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Acute Migraine Medications Market Facts & Figures by Country
3.7.1 Middle East and Africa Acute Migraine Medications Sales by Country
3.7.2 Middle East and Africa Acute Migraine Medications Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Acute Migraine Medications Historic Market Analysis by Type
4.1 Global Acute Migraine Medications Sales Market Share by Type (2016-2021)
4.2 Global Acute Migraine Medications Revenue Market Share by Type (2016-2021)
4.3 Global Acute Migraine Medications Price by Type (2016-2021)

5 Global Acute Migraine Medications Historic Market Analysis by Application
5.1 Global Acute Migraine Medications Sales Market Share by Application (2016-2021)
5.2 Global Acute Migraine Medications Revenue Market Share by Application (2016-2021)
5.3 Global Acute Migraine Medications Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Corporation Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sun Pharma Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Grunenthal
6.6.1 Grunenthal Corporation Information
6.6.2 Grunenthal Description and Business Overview
6.6.3 Grunenthal Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Grunenthal Product Portfolio
6.7.5 Grunenthal Recent Developments/Updates
6.8 Endo Pharmaceuticals
6.8.1 Endo Pharmaceuticals Corporation Information
6.8.2 Endo Pharmaceuticals Description and Business Overview
6.8.3 Endo Pharmaceuticals Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Endo Pharmaceuticals Product Portfolio
6.8.5 Endo Pharmaceuticals Recent Developments/Updates

7 Acute Migraine Medications Manufacturing Cost Analysis
7.1 Acute Migraine Medications Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Acute Migraine Medications
7.4 Acute Migraine Medications Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Acute Migraine Medications Distributors List
8.3 Acute Migraine Medications Customers

9 Acute Migraine Medications Market Dynamics
9.1 Acute Migraine Medications Industry Trends
9.2 Acute Migraine Medications Growth Drivers
9.3 Acute Migraine Medications Market Challenges
9.4 Acute Migraine Medications Market Restraints

10 Global Market Forecast
10.1 Acute Migraine Medications Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Acute Migraine Medications by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Acute Migraine Medications by Type (2022-2027)
10.2 Acute Migraine Medications Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Acute Migraine Medications by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Acute Migraine Medications by Application (2022-2027)
10.3 Acute Migraine Medications Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Acute Migraine Medications by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Acute Migraine Medications by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Acute Migraine Medications Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Acute Migraine Medications Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Acute Migraine Medications Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Acute Migraine Medications Covered in This Study
Table 5. Global Acute Migraine Medications Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Acute Migraine Medications Sales Share by Manufacturers (2016-2021)
Table 7. Global Acute Migraine Medications Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Acute Migraine Medications Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Acute Migraine Medications Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Acute Migraine Medications Manufacturing Sites and Area Served
Table 11. Manufacturers Acute Migraine Medications Product Type
Table 12. Global Acute Migraine Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Acute Migraine Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Medications as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Acute Migraine Medications Sales by Region (2016-2021) & (K Units)
Table 16. Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
Table 17. Global Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 19. North America Acute Migraine Medications Sales Market Share by Country (2016-2021)
Table 20. North America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Acute Migraine Medications Revenue Market Share by Country (2016-2021)
Table 22. Europe Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 23. Europe Acute Migraine Medications Sales Market Share by Country (2016-2021)
Table 24. Europe Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Acute Migraine Medications Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Acute Migraine Medications Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Acute Migraine Medications Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Acute Migraine Medications Revenue Market Share by Region (2016-2021)
Table 30. Latin America Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Acute Migraine Medications Sales Market Share by Country (2016-2021)
Table 32. Latin America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Acute Migraine Medications Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Acute Migraine Medications Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Acute Migraine Medications Revenue Market Share by Country (2016-2021)
Table 38. Global Acute Migraine Medications Sales (K Units) by Type (2016-2021)
Table 39. Global Acute Migraine Medications Sales Market Share by Type (2016-2021)
Table 40. Global Acute Migraine Medications Revenue (Million US$) by Type (2016-2021)
Table 41. Global Acute Migraine Medications Revenue Share by Type (2016-2021)
Table 42. Global Acute Migraine Medications Price (US$/Unit) by Type (2016-2021)
Table 43. Global Acute Migraine Medications Sales (K Units) by Application (2016-2021)
Table 44. Global Acute Migraine Medications Sales Market Share by Application (2016-2021)
Table 45. Global Acute Migraine Medications Revenue (Million US$) by Application (2016-2021)
Table 46. Global Acute Migraine Medications Revenue Share by Application (2016-2021)
Table 47. Global Acute Migraine Medications Price (US$/Unit) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. GSK Acute Migraine Medications Product
Table 52. GSK Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Teva Acute Migraine Medications Product
Table 57. Teva Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Acute Migraine Medications Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Novartis Acute Migraine Medications Product
Table 67. Novartis Recent Developments/Updates
Table 68. Merck Corporation Information
Table 69. Merck Description and Business Overview
Table 70. Merck Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Merck Acute Migraine Medications Product
Table 72. Merck Recent Developments/Updates
Table 73. Sun Pharma Corporation Information
Table 74. Sun Pharma Description and Business Overview
Table 75. Sun Pharma Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Sun Pharma Acute Migraine Medications Product
Table 77. Sun Pharma Recent Developments/Updates
Table 78. Grunenthal Corporation Information
Table 79. Grunenthal Description and Business Overview
Table 80. Grunenthal Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Grunenthal Acute Migraine Medications Product
Table 82. Grunenthal Recent Developments/Updates
Table 83. Endo Pharmaceuticals Corporation Information
Table 84. Endo Pharmaceuticals Description and Business Overview
Table 85. Endo Pharmaceuticals Acute Migraine Medications Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Endo Pharmaceuticals Acute Migraine Medications Product
Table 87. Endo Pharmaceuticals Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Acute Migraine Medications Distributors List
Table 91. Acute Migraine Medications Customers List
Table 92. Acute Migraine Medications Market Trends
Table 93. Acute Migraine Medications Growth Drivers
Table 94. Acute Migraine Medications Market Restraints
Table 95. Global Acute Migraine Medications Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Acute Migraine Medications Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Acute Migraine Medications Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Acute Migraine Medications Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Acute Migraine Medications Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Acute Migraine Medications Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Acute Migraine Medications Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Acute Migraine Medications Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Acute Migraine Medications Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Acute Migraine Medications Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Acute Migraine Medications Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Acute Migraine Medications Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Acute Migraine Medications
Figure 2. Global Acute Migraine Medications Market Share by Type in 2020 & 2027
Figure 3. Triptans Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acute Migraine Medications Market Share by Application in 2020 & 2027
Figure 7. Drug Stores
Figure 8. Hospital Pharmacies
Figure 9. Global Acute Migraine Medications Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Acute Migraine Medications Market Size 2016-2027 (US$ Million)
Figure 11. Global Acute Migraine Medications Sales 2016-2027 (K Units)
Figure 12. Global Acute Migraine Medications Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Acute Migraine Medications Sales Share by Manufacturers in 2020
Figure 14. Global Acute Migraine Medications Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Acute Migraine Medications Players: Market Share by Revenue in 2020
Figure 16. Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
Figure 18. Global Acute Migraine Medications Sales Market Share by Region in 2020
Figure 19. Global Acute Migraine Medications Revenue Market Share by Region (2016-2021)
Figure 20. Global Acute Migraine Medications Revenue Market Share by Region in 2020
Figure 21. U.S. Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Acute Migraine Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Acute Migraine Medications by Type (2016-2021)
Figure 46. Sales Market Share of Acute Migraine Medications by Application (2016-2021)
Figure 47. Sales Market Share of Acute Migraine Medications by Application in 2020
Figure 48. Revenue Share of Acute Migraine Medications by Application (2016-2021)
Figure 49. Revenue Share of Acute Migraine Medications by Application in 2020
Figure 50. Manufacturing Cost Structure of Acute Migraine Medications
Figure 51. Manufacturing Process Analysis of Acute Migraine Medications
Figure 52. Acute Migraine Medications Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed